Akari Therapeutics PLC (AKTX) Stock Scores High After 34% Gain

 

Akari Therapeutics PLC (AKTX) stock is up more than 34% Tuesday and has risen 129.59% over the last 12 months. The average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AKTX stock a score of 89 out of a possible 100.

That score is primarily influenced by a long-term technical score of 99. AKTX’s score also includes a short-term technical score of 92. The fundamental score for AKTX is 77. In addition to the average rating from Wall Street analysts, AKTX stock has a mean target price of $7.00. This means analysts expect the stock to increase 55.56% over the next 12 months.

Click Here to get the full Stock Score Report on Akari Therapeutics PLC (AKTX).

What’s Happening with AKTX Stock Today

Akari Therapeutics PLC (AKTX) stock has risen 34.33% while the S&P 500 has risen 0.25% as of 10:06 AM on Tuesday, Apr 23. AKTX has risen $1.15 from the previous closing price of $3.35 on volume of 8,545,689 shares. Over the past year the S&P 500 is up 9.17% while AKTX has risen 129.59%. AKTX lost -$2.84 per share in the over the last 12 months.

Symbols: AKTX

You May Also Like